← Leaderboards
Val J Watts
Purdue University
$6,232,901
Attributed
$8,831,286
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $845.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,831,286 · 10
By mechanism
R01$4,966,405 · 2
R33$1,711,407 · 2
R21$1,538,899 · 4
R61$442,933 · 1
R03$171,642 · 1
Top collaborators
- Daniel Patrick Flaherty7 shared
- David L Roman5 shared
- Carmen W Dessauer4 shared
- Catherine A Hill2 shared
- Chang-Deng Hu2 shared
- Hongxia Ren1 shared
Most similar at Purdue University
Same institution · by research overlap
- Daniel Patrick Flaherty$5,322,335
- Casey John Krusemark$3,050,197
- Catherine A Hill$215,152
- Chang-Deng Hu$960,640
Others in their field
Top investigators on “Adenylate Cyclase”
- Stephen F Vatner · Univ Of Med/Dent Of Nj-Nj Medical School$15,473,498
- Lonny R Levin · Weill Medical College Of Cornell Univ$15,462,855
- Jochen Buck · Weill Medical College Of Cornell Univ$14,681,913
- Dennis Brown · Massachusetts General Hospital$13,042,858
- Daniel R Storm · University Of Washington$11,877,486
- Pedro A. Jose · George Washington University$10,827,484
Research focus
Adenylate CyclaseCyclic AmpPharmaceutical PreparationsSpecificityNeuronsPreventLeadProtein IsoformsSignal TransductionCellsScreeningDesignBaseIn VivoSeriesResponseAcuteG-Protein-Coupled ReceptorsReceptorMolecularAddictionReceptor CouplingPharmacologyIn Vitro
Grant awards (33)
Pharmacological validation of adenylyl cyclase 1 as a drug target for chronic pain$337,908
R01 · FY2025 · NS
Pharmacological validation of adenylyl cyclase 1 as a drug target for chronic pain$69,619
R01 · FY2025 · NS
Pharmacological validation of adenylyl cyclase 1 as a drug target for chronic pain$364,418
R01 · FY2024 · NS
Pharmacological validation of adenylyl cyclase 1 as a drug target for chronic pain$63,436
R01 · FY2024 · NS
Pharmacological validation of adenylyl cyclase 1 as a drug target for chronic pain$375,921
R01 · FY2023 · NS
Non-Opioids for Inflammatory Pain: Adenylyl Cyclase 1 as a Novel Target$409,008
R33 · FY2022 · NS
Pharmacological validation of adenylyl cyclase 1 as a drug target for chronic pain$376,148
R01 · FY2022 · NS
Non-Opioids for Inflammatory Pain: Adenylyl Cyclase 1 as a Novel Target$60,140
R33 · FY2022 · NS
Pharmacological validation of adenylyl cyclase 1 as a drug target for chronic pain$376,148
R01 · FY2021 · NS
Non-opioids for inflammatory pain: Adenylyl cyclase 1 as a novel target$353,242
R33 · FY2021 · NS
Illuminating the Metabolic Function of GPR162 by Delineating Downstream Signaling Pathways and Characterizing Hypothalamic Expression Pattern$171,642
R03 · FY2020 · TR
Non-opioids for inflammatory pain: Adenylyl cyclase 1 as a novel target$400,720
R61 · FY2019 · NS
Non-opioids for inflammatory pain: Adenylyl cyclase 1 as a novel target$42,213
R61 · FY2019 · NS
New mode-of-action chemistries for mosquito control$234,562
R21 · FY2017 · AI
Understanding adaptive signaling of neuronal adenyly cyclases using siRNA$442,159
R33 · FY2016 · MH · contact PI
New mode-of-action chemistries for mosquito control$195,742
R21 · FY2016 · AI
Understanding adaptive signaling of neuronal adenyly cyclases using siRNA$446,858
R33 · FY2015 · MH · contact PI
Understanding adaptive signaling of neuronal adenyly cyclases using siRNA$260,639
R21 · FY2014 · MH · contact PI
Identification of the AC5 sensitization interactome using BiFC$238,253
R21 · FY2014 · MH · contact PI
Identification of the AC5 sensitization interactome using BiFC$197,858
R21 · FY2013 · MH · contact PI
D2 Receptor Induced Sensitization of Adenylate Cyclase$378,283
R01 · FY2012 · MH · contact PI
D2 Receptor Induced Sensitization of Adenylate Cyclase$406,138
R01 · FY2011 · MH · contact PI
Development of Allosteric Modulators of D1 Dopamine Receptors$186,786
R21 · FY2010 · MH · contact PI
D2 Receptor-Induced Sensitization of Adenylate Cyclase$249,459
R01 · FY2009 · MH · contact PI
Development of Allosteric Modulators of D1 Dopamine Receptors$225,059
R21 · FY2009 · MH · contact PI
D2 Receptor-Induced Sensitization of Adenylate Cyclase$250,084
R01 · FY2008 · MH · contact PI
D2 Receptor-Induced Sensitization of Adenylate Cyclase$250,671
R01 · FY2007 · MH · contact PI
D2 Receptor-Induced Sensitization of Adenylate Cyclase$258,722
R01 · FY2006 · MH · contact PI
D2 Receptor-Induced Sensitization of Adenylate Cyclase$287,971
R01 · FY2005 · MH
D2 RECEPTOR-INDUCED SENSITIZATION OF ADENYLATE CYCLASE$223,499
R01 · FY2003 · MH
D2 RECEPTOR-INDUCED SENSITIZATION OF ADENYLATE CYCLASE$223,894
R01 · FY2002 · MH
D2 RECEPTOR-INDUCED SENSITIZATION OF ADENYLATE CYCLASE$224,256
R01 · FY2001 · MH
D2 RECEPTOR-INDUCED SENSITIZATION OF ADENYLATE CYCLASE$249,830
R01 · FY2000 · MH